Investors are deploying less capital in biotech startups as a cloudy market outlook and a dearth of IPOs hobble the sector.
Source link
Venture Interest Slackens in Once-Hot Biotech
Related Posts
AI, Fancy Footwear, and All the Other Gear Powering Olympic Bobsledding
Olympic bobsledding usually will get known as the “System 1 of ice.” Tracks are greater than 1.5 kilometers (almost a…
SoftBank’s Son ‘was crying’ about the firm’s need to sell its Nvidia stake AI Bets
Masayoshi Son, chairman and chief govt officer of SoftBank Group Corp., speaks on the SoftBank World occasion in Tokyo, Japan,…
Corporate Real Estate AI Pilots Surge, ROI Still Elusive: Report
Regardless of widespread adoption, company actual property companies battle to translate AI pilot tasks into measurable ROI, a brand new…